| S.No |
Name |
Thesis Title |
Year started |
Status |
| 1 |
Mr. Almesh Kadakol (Supervisor) |
Role of angiotensin II on vascular epigenetics in the development of atherosclerosis and therapeutic intervention of esculetin under type 2 diabetic conditions associated with renal failure |
Feb 2013 |
Completed on 23rd April 2018
|
| 2 |
Mr. Santosh Kumar Goru (Supervisor) |
Role of histone ubiquitination and ACE2 activation in the progression of renal fibrosis in type I diabetic kidney |
Jan 2014 |
Completed on 9th Jan 2018
|
| 3 |
Ms. Anuradha Pandey (Supervisor) |
Role of epigenetics in modulating inflammatory response mediated by NF-kB through AT1 or AT2 receptor in the development of renal failure under type II diabetic condition |
Jan 2014 |
Completed on 21st March 2018
|
| 4 |
Mr. Malek Vajir (Supervisor) |
Role of neprilysin in the development of cardiovascular and renal complications associated with type 1 diabetes. |
Jan 2015 |
Completed on 5th Feb 2020
|
| 5 |
Ms. Nisha Sharma (Supervisor) |
Involvement of Histone H3 Methylation, Angiotensin converting enzyme 2, and Angiotensin II type 2 receptor in the pathogenesis of acute kidney injury under type 1 diabetic and non-diabetic conditions |
Jan 2016 |
Completed on 22nd October 2020 |
| 6 |
Mr. Himanshu
Sankrityayan (Supervisor) |
Understanding the role and regulation of endoplasmic stress in the development of endothelial dysfunction and kidney disease under type 1 diabetic condition |
July
2018 |
Completed on 27th September 2022 |
| 7 | Mr. Prabhjeet Singh (Co-supervisor) | Actively targeted nano-carrier system for the co-delivery of temozolomide and an autophagy modulator for the treatment of glioblastoma multiforme | Dec 2019 | Work in pogress |
| 8 |
Mr. Ajinath Kale (Supervisor) |
Klotho regulation as a novel therapeutic strategy against acute kidney injury-diabetes comorbidity |
Jan 2020 |
Thesis submitted on 25th April 2023 |
| 9 | Mr. Vishwadeep Shelke (Supervisor)
| Study of novel therapeutic strategies targeting toll-like receptors 2 and 4 (TLR2/4) against acute kidney injury under diabetic condition
| Oct 2020
| Work in progress
|
| 10 | Ms. Ankita Sharma
(Co-supervisor)
| Understanding hyperglycemia-induced epigenetic alterations contributing to drug resistance and progression of human pancreatic cancer | Dec 2020
| Work in progress
|
| 11 | Ms. Neha Dagar (Supervisor) | Evaluating the role and putative mechanisms of selected nutraceuticals against acute kidney injury under diabetic condition based on network pharmacology approach and experimental validation | Sept 2021 | Work in progress |
| 12 | Ms. Shikha Thakur (Co-Supervisor) | Design, synthesis, and biological evaluation of Angiotensin II type 1 receptor (AT1R) – neprilysin (NEP) inhibitors (ARNi) against diabetic cardiomyopathy (DCM) | Sept 2021 | Work in progress |